Global Multiple Sclerosis Drugs Market Global Opportunity Analysis, End User, and Geography— Industry Forecasts 2023-2030
The Global Multiple Sclerosis Drugs Market size is expected to grow from USD 28.83 billion in 2022 to USD 41.95 billion by 2030, at a CAGR of 4.8% during the forecast period (2023-2030).   Multiple sclerosis (MS) is a chronic neurological disease caused by an unknown inflammatory process in the central nervous system (CNS), resulting in multifocal demyelination and axonal loss primarily...
0 Comments 0 Shares